CPRX — Catalyst Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $2.40bn
- $2.02bn
- $398.20m
- 84
- 38
- 86
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 31.9 | 75 | 39.5 | 83.1 | 71.4 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 3.78 | 7.04 | 6.36 | 13.1 | 94.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.1 | -4.11 | 5.02 | 13.7 | -37.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | 34.6 | 45 | 60.4 | 116 | 144 |
Capital Expenditures | -0.019 | -0.011 | -1.02 | -0.029 | -0.231 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 37.2 | -5 | -10 | 9.24 | -293 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 37.2 | -5.01 | -11 | 9.21 | -294 |
Financing Cash Flow Items | 0 | -0.056 | -0.153 | -0.968 | -13.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 1.12 | 0.702 | -8.14 | 1.69 | -10.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 73 | 40.7 | 41.2 | 127 | -161 |